NPI registry status
Active
2026 NPPES data Research Study Specialist NPI 1174256622 MD
Verify on CMS → Dania Al Jabri, MD
Research Study Specialist in Augusta, Georgia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 485 in Research Study Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
373
Medicare Part D claims · 42 beneficiaries · Research Study Specialist avg: 601
Industry payments
$14.78
1 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Dania Al Jabri, MD filed 373 Medicare Part D claims in 2023 as a Research Study Specialist in Augusta, Georgia.
- 373
- Part D claims, 2023
- $14.78
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Dania Al Jabri, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
373 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Dania Al Jabri, MD?
Quality data not reportedPrimary specialty
Research Study Specialist
Medicare Part D claims
373 38% vs specialty avg
Specialty distribution in Georgia
How Research Study Specialist compares to other specialties among Georgia providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Research Study Specialist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Dania Al Jabri, MD appears in the CMS NPPES registry as a Research Study Specialist provider holding MD credentials at 1120 15TH ST, Augusta, GA, 30912, with a listed phone of (860) 328-8970. NPI 1174256622 was issued on 07/01/2022.
Medicare Part D records for calendar year 2023 show 373 prescription claims written by this provider, covering 42 Medicare beneficiaries and totaling roughly $79K in drug spend.
Research Study Specialist is a narrow specialty nationwide, with 485 enrolled providers across 42 states and an average of 601 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1174256622 |
|---|---|
| Specialty | Research Study Specialist |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/01/2022 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Dania Al Jabri, MD. Source: openpaymentsdata.cms.gov.
Total received
$15
Largest payer
Radius Health, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
373
Total Claims
$79K
Total Drug Cost
42
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 757
- Total Day Supply
- 22,275
- Generic Drug Cost
- $12K
Patient Demographics
- Average Patient Age
- 65.4 years
- Avg HCC Risk Score
- 2.28
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 16, 65-74: 17, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Dania Al Jabri, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
18 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
17 claims
- Farxiga
Farxiga
15 claims
- Diclofenac Sodium
Diclofenac Sodium
13 claims
- Hydralazine Hcl
Hydralazine Hcl
13 claims
- Amlodipine Besylate
Amlodipine Besylate
11 claims
- Eliquis
Eliquis
11 claims
- Gabapentin
Gabapentin
11 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 18 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 17 |
| Farxiga Dapagliflozin Propanediol | 15 |
| Diclofenac Sodium | 13 |
| Hydralazine Hcl | 13 |
| Amlodipine Besylate | 11 |
| Eliquis Apixaban | 11 |
| Gabapentin | 11 |
| Lisinopril | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Research Study Specialist Overview
How Dania Al Jabri, MD fits within the Research Study Specialist landscape nationally.
485
Research Study Specialist Providers in US
42
States with Research Study Specialist
601
Avg Claims per Provider
Dania Al Jabri, MD's 373 claims are below the specialty average of 601.
Nearby Research Study Specialist Providers in Georgia
Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as Al Jabri.
Chidi Asuzu
Dallas, GA
Dr. Kayhan Bolelli
PHD
Stone Mountain, GA
Dr. Kenneth Dominguez
MD
Atlanta, GA
James Ellison
Atlanta, GA
Dr. Sammy Elmor
B.S.
Decatur, GA
Compare Research Study Specialist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Georgia medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Research Study Specialist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Georgia
Frequently Asked Questions
What is Dania Al Jabri, MD's specialty? ▼
Dania Al Jabri, MD specializes in Research Study Specialist and practices in Augusta, Georgia. Credentials: MD.
How much does Dania Al Jabri, MD prescribe under Medicare Part D? ▼
In 2023, Dania Al Jabri, MD wrote 373 Medicare Part D claims totaling $79K in drug costs for 42 beneficiaries.
Where is Dania Al Jabri, MD located? ▼
Dania Al Jabri, MD is located at 1120 15TH ST, Augusta, GA, 30912. Phone: (860) 328-8970.
What is Dania Al Jabri, MD's NPI number? ▼
Dania Al Jabri, MD's National Provider Identifier (NPI) is 1174256622, issued on 07/01/2022.
How many Research Study Specialist providers are there in the US? ▼
There are 485 Research Study Specialist providers across 42 states in the US. The average Research Study Specialist provider writes 601 Medicare Part D claims per year.
What drugs does Dania Al Jabri, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Dania Al Jabri, MD's most frequently prescribed drugs include Atorvastatin Calcium, Albuterol Sulfate Hfa, Farxiga. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Dania Al Jabri, MD accept Medicare? ▼
Dania Al Jabri, MD appears in CMS Medicare data with 373 Part D claims and 42 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Dania Al Jabri, MD's credentials? ▼
Dania Al Jabri, MD's NPI is 1174256622 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.